15.11.2012 Views

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Medicinal</strong> <strong>Plants</strong>: A Tool to Overcome Antibiotic Resistance?<br />

4.1. Efflux Pumps Inhibitors<br />

4.1.1. Efflux Systems<br />

Among the major mechanisms involved in bacterial resistance, efflux pumps, responsible<br />

for the extrusion <strong>of</strong> the antibiotic outside the cell, have recently received a particular<br />

attention. These systems can confer resistance to a specific class <strong>of</strong> antibiotics or to a large<br />

number <strong>of</strong> drugs, thus conferring a multi-drug resistance to bacteria. Efflux pumps are<br />

currently classified into five families:<br />

� ATP-binding cassette (ABC) transporters are ubiquitous membrane systems involved<br />

in different transport functions such as the efflux <strong>of</strong> toxins, metabolites <strong>and</strong> drugs.<br />

Bacterial ABC transporters involved in drug resistance are mainly drug-specific<br />

transporters <strong>and</strong> many <strong>of</strong> them are found in antibiotic producing organisms, such as<br />

Streptomyces spp, thus ensuring self-resistance to the drug they produce. In some<br />

Gram positive bacteria, such as Staphylococci <strong>and</strong> Enterococci, such specific<br />

transporters are also found, conferring resistance to macrolides <strong>and</strong> related<br />

compounds (Holl<strong>and</strong>, 2003).<br />

� Major facilitator superfamily (MFS) are ubiquitous systems ensuring transport <strong>of</strong><br />

sugars, intermediate metabolites <strong>and</strong> drugs.<br />

� Resistance nodulation <strong>and</strong> cell division (RDN) are involved in the transport <strong>of</strong><br />

lipophilic <strong>and</strong> amphiphilic molecules or toxic divalent cations, also responsible for<br />

the solvent resistance <strong>of</strong> some bacterial strains. They are mainly found in Gram<br />

negative bacteria.<br />

� Small multi-drugs resistance (SMR) are the smallest drug efflux proteins known,<br />

involved in the efflux <strong>of</strong> lipophilic cationic drugs.<br />

� Multi-drug <strong>and</strong> toxic compounds extrusion (MATE) are mainly Na + /drug antiporters<br />

in contrast to the other families <strong>of</strong> secondary transporters which act as proton/drug<br />

antiporters.<br />

These five families <strong>of</strong> efflux pumps are commonly grouped in two major groups based<br />

upon bioenergetical <strong>and</strong> structural features: (i) the primary transporters which hydrolyze ATP<br />

as source <strong>of</strong> energy (ABC transporters); <strong>and</strong> (ii) the secondary transporters which use the<br />

proton (or sodium) gradient as source <strong>of</strong> energy (MFS, RDN, SMR <strong>and</strong> MATE). In bacteria,<br />

secondary transporters are dominant <strong>and</strong> many <strong>of</strong> them are multi-drugs resistance<br />

transporters, whereas ABC transporters are mainly specific drug resistance transporters.<br />

In Gram positive bacteria, MDR is mainly conferred by MFS efflux systems, the most<br />

studied being NorA <strong>of</strong> Staphylococcus aureus <strong>and</strong> its homologues in Bacillus subtilis, Mmr<br />

<strong>and</strong> Blt. Whereas RDN efflux systems are major contributors to resistance for Gram negative<br />

bacteria, AcrAB-TolC <strong>and</strong> MexAB-OprM are also involved in the intrinsic resistance <strong>of</strong><br />

Escherichia coli <strong>and</strong> Pseudomonas aeruginosa, respectively.<br />

4.1.2. Efflux Pumps Inhibitors (EPIs)<br />

The research <strong>of</strong> compounds inhibiting the efflux pumps is crucial in the fight against<br />

antibiotic resistance. These compounds are expected to: (i) decrease the intrinsic resistance <strong>of</strong><br />

327

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!